IdentificationGeneric Name(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOLDrugBank Accession NumberDB07909BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL (DB07909)× CloseWeightAverage: 381.4648 Monoisotopic: 381.194008357 Chemical FormulaC23H27NO4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUUncharacterized proteinNot AvailableHumansUIg gamma-1 chain C regionNot AvailableHumansUIg kappa chain C regionNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentGamma amino acids and derivativesAlternative ParentsBenzamides / Benzoyl derivatives / Cyclohexanols / Secondary carboxylic acid amides / Cyclic alcohols and derivatives / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituentsAlcohol / Aromatic homomonocyclic compound / Benzamide / Benzenoid / Benzoic acid or derivatives / Benzoyl / Carbonyl group / Carboxamide group / Carboxylic acid / Cyclic alcohol / Cyclohexanol / Gamma amino acid or derivatives / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Secondary alcohol / Secondary carboxylic acid amide


 show 13 moreMolecular FrameworkAromatic homomonocyclic compoundsExternal Descriptorsmonocarboxylic acid, cyclohexanols (CHEBI:43278) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyOBWILOKKNDYPLX-HBMCJLEFSA-NInChIInChI=1S/C23H27NO4/c25-21-15-19(16-5-2-1-3-6-16)12-13-20(21)17-8-10-18(11-9-17)23(28)24-14-4-7-22(26)27/h1-3,5-6,8-11,19-21,25H,4,7,12-15H2,(H,24,28)(H,26,27)/t19-,20+,21-/m0/s1IUPAC Name4-({4-[(1R,2S,4S)-2-hydroxy-4-phenylcyclohexyl]phenyl}formamido)butanoic acidSMILES[H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound444394PubChem Substance99444380ChemSpider392337ChEBI43278ZINCZINC000006582201PDBe LigandHOPPDB Entries1axs / 1d6vClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00298 mg/mLALOGPSlogP3.3ALOGPSlogP3.28ChemaxonlogS-5.1ALOGPSpKa (Strongest Acidic)4.14ChemaxonpKa (Strongest Basic)-0.72ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area86.63 Å2ChemaxonRotatable Bond Count7ChemaxonRefractivity108 m3·mol-1ChemaxonPolarizability43.82 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9771Blood Brain Barrier+0.8735Caco-2 permeable-0.6839P-glycoprotein substrateNon-substrate0.56P-glycoprotein inhibitor INon-inhibitor0.812P-glycoprotein inhibitor IINon-inhibitor0.6265Renal organic cation transporterNon-inhibitor0.7699CYP450 2C9 substrateNon-substrate0.7849CYP450 2D6 substrateNon-substrate0.8287CYP450 3A4 substrateSubstrate0.5152CYP450 1A2 substrateNon-inhibitor0.9343CYP450 2C9 inhibitorNon-inhibitor0.9454CYP450 2D6 inhibitorNon-inhibitor0.8363CYP450 2C19 inhibitorNon-inhibitor0.9179CYP450 3A4 inhibitorNon-inhibitor0.8546CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.913Ames testNon AMES toxic0.8625CarcinogenicityNon-carcinogens0.9325BiodegradationNot ready biodegradable0.52Rat acute toxicity2.0055 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9611hERG inhibition (predictor II)Non-inhibitor0.665  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Uncharacterized proteinKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionNot AvailableSpecific FunctionNot AvailableGene NameNot AvailableUniprot IDQ7Z3Y4Uniprot NameUncharacterized proteinMolecular Weight25701.705 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. Ig gamma-1 chain C regionKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionImmunoglobulin receptor bindingSpecific FunctionNot AvailableGene NameIGHG1Uniprot IDP01857Uniprot NameIg gamma-1 chain C regionMolecular Weight36105.695 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details3. Ig kappa chain C regionKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionImmunoglobulin receptor bindingSpecific FunctionNot AvailableGene NameIGKCUniprot IDP01834Uniprot NameIg kappa chain C regionMolecular Weight11608.765 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 